Aurobindo Pharma Ltd (Unit 1) is setting up a pharmaceutical formulation unit at Sy. No. 107, 108, 113, MPSEZ Naidupeta, Naidupeta Mandal, Tirupati District, Andhra Pradesh, spread over an area of 10 acres, at a project cost of Rs. 3292.3 Million. The facility has received Consent to Establish from the State Pollution Control Board to manufacture tablets (3750 million/annum), capsules (2500 million/annum), syrups (25 million/annum), dry powder injections (50 million/annum) and sterile lyophilized powder injections (30 million/annum), using key raw materials such as Amoxicillin Trihydrate, Clavulanate Potassium, Cloxacillin Sodium, Dicloxacillin Sodium, Flucloxacillin Sodium, Isopropyl Alcohol, Methylene Chloride and Microcrystalline Cellulose. The plant is expected to be equipped with an effluent treatment system for 155 KLD of industrial wastewater linked to the Naidupeta CETP, a sewage treatment plant of 75-100 KLD capacity, briquette-fired boilers (6 TPH and 1 TPH) with bag filters, a hot water generator, DG sets with acoustic enclosures, and hazardous waste storage and handling infrastructure, along with associated utilities such as bore-well based water supply, storm water drains, rainwater harvesting structures and greenbelt development across at least 33% of the site.